Pharmaceuticals News
Source: Google
Pharmaceuticals News
Is OliX Pharmaceuticals’ release of phase
Is OliX Pharmaceuticals’ release of phase 2 results of OLX101A a half success? KBR
Posted on 25 April 2024 | 9:08 pm
CSPC Innovation Pharmaceutical First Quarter
CSPC Innovation Pharmaceutical First Quarter 2024 Earnings: EPS: CN¥0.056 (vs CN¥0.095 in 1Q 2023) Simply Wall St
Posted on 25 April 2024 | 6:45 pm
Recce Pharmaceuticals R327 approved for
Recce Pharmaceuticals R327 approved for increase to 4000mg IV over a fast infusion of 30 minutes Proactive Investors USA
Posted on 25 April 2024 | 6:30 pm
Zhi Tian Lai Buys Handful Of Shares In
Zhi Tian Lai Buys Handful Of Shares In Zhongzhi Pharmaceutical Holdings Simply Wall St
Posted on 25 April 2024 | 6:13 pm
Sinco Pharmaceuticals Holdings Full Year
Sinco Pharmaceuticals Holdings Full Year 2023 Earnings: EPS: CN¥0.021 (vs CN¥0.034 in FY 2022) Simply Wall St
Posted on 25 April 2024 | 6:01 pm
Source: Yahoo
Pharmaceuticals News
China Shineway Pharmaceutical Group
China Shineway Pharmaceutical Group (HKG:2877) Has Announced That It Will Be Increasing Its Dividend To CN¥0.461 Simply Wall St
Posted on 25 April 2024 | 5:17 pm
Zhiguo Zheng Zhejiang Ausun Pharmaceutical
Zhiguo Zheng Zhejiang Ausun Pharmaceutical Co., Ltd.'s (SHSE:603229) CEO is the most bullish insider, and their stock value gained 6.9%last week Simply Wall St
Posted on 25 April 2024 | 4:38 pm
SF Bay pharmaceutical toxins effect an
SF Bay pharmaceutical toxins effect an open-ended question | Climate | sfexaminer.com San Francisco Examiner
Posted on 25 April 2024 | 3:25 pm
While shareholders of JiangSu WuZhong
While shareholders of JiangSu WuZhong Pharmaceutical Development (SHSE:600200) are in the black over 5 years, those who bought a week ago aren't so fortunate Simply Wall St
Posted on 25 April 2024 | 3:13 pm
JiangSu WuZhong Pharmaceutical Development
JiangSu WuZhong Pharmaceutical Development Full Year 2023 Earnings: Misses Expectations Simply Wall St
Posted on 25 April 2024 | 3:12 pm
Source: Bing
Pharmaceuticals News
Hunan Jiudian Pharmaceutical First Quarter
Hunan Jiudian Pharmaceutical First Quarter 2024 Earnings: EPS: CN¥0.36 (vs CN¥0.22 in 1Q 2023) Simply Wall St
Posted on 25 April 2024 | 3:12 pm
National Capacity Variance/Generator Status:
National Capacity Variance/Generator Status: U.S. Environmental Protection Agency Guidance Addresses Hazardous ... JD Supra
Posted on 25 April 2024 | 2:56 pm
Gilead posts quarterly loss on acquisition
Gilead posts quarterly loss on acquisition charge, revenue rises 5% Reuters.com
Posted on 25 April 2024 | 2:07 pm
Fusion Pharmaceuticals Mails Circular for
Fusion Pharmaceuticals Mails Circular for Special Meeting of Shareholders and Announces Receipt of Interim Order PR Newswire
Posted on 25 April 2024 | 1:34 pm
Ironwood Pharmaceuticals to Host First
Ironwood Pharmaceuticals to Host First Quarter 2024 Investor Update Call Business Wire
Posted on 25 April 2024 | 1:01 pm